Curaleaf's current CEO Joe Bayern will launch and run a new division of Curaleaf.
The appointment will be made following suspension of the company’s shares from the AQSE.
Apollon Formularies has announced the acquisition of four patents previously owned by AI Pharmaceuticals, covering a number of treatments for cancers and inflammation using cannabis and...
The US-based company operating primarily in Switzerland has plans to expand into the German market.
The platform aims to be a premium destination for industry members to connect.
Akanda has now completed its acquisition of Holigen Limited from The Flowr Corporation.
The acquisition is a cornerstone of Halo’s shareholder value enhancement strategy, says CEO.
The CBD industry remains a 'wild west' with recent data finding an alarming number of companies mislabelling or failing to test their products for purity and...
The recent loans will support SMEs in Denver and Las Vegas across retail, cultivation and extraction.
MGC Pharma, Cansativa Group and Somai Pharmaceuticals will be sponsoring the event.